In a recent study published in the Journal of American Medical Association (JAMA) Network Open, researchers found an association between male hypogonadism and hospitalization risk for coronavirus ...

DUBLIN--(BUSINESS WIRE)--The "Male Hypogonadism - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Male Hypogonadism - Pipeline Review, H2 2018, provides ...

This article was reviewed by Peter J. Stahl, MD. The medical term for testosterone deficiency that causes symptoms is male hypogonadism. Testosterone is one of the most important hormones for men. If ...

The data showed that 87% of men who received Jatenzo achieved an average testosterone level within normal range The Food and Drug Administration (FDA) has approved Jatenzo (testosterone undecanoate; ...

Male hypogonadism means your body isn’t making enough testosterone, the hormone that plays a role in drive, energy, and muscle strength. Primary hypogonadism starts … ...

Kyzatrex is an investigational, oral testosterone undecanoate softgel that utilizes lymphatic absorption and phytosterols to increase bioavailability and provide a favorable pharmacokinetic profile.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Men with low ...

SAN FRANCISCO — Adherence to diagnostic and treatment guidelines for male hypogonadism is quite low, with significant differences among medical specialists, a new study found. Off-label use of ...

Men with low testosterone levels are more likely to require hospitalization after COVID-19 infection than men with normal levels or those on testosterone therapy, according to Saint Louis University ...

The Food and Drug Administration (FDA) has approved Jatenzo (testosterone undecanoate; Clarus Therapeutics) capsules for testosterone replacement therapy in adult males for conditions associated with ...